[Federal Register Volume 84, Number 250 (Tuesday, December 31, 2019)]
[Notices]
[Pages 72367-72368]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-28249]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2013-N-0134; FDA-2011-N-0902; FDA-2013-N-0662; FDA-
2013-N-0242; FDA-2019-N-1517; FDA-2019-N-0549; FDA-2019-N-0305; FDA-
2012-N-0477; FDA-2016-D-2565, and FDA-2018-N-4839]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Mammography Quality Standards Act 0910-0309 10/31/2022
Requirements...........................
Prescription Drug Product Labeling; 0910-0393 10/31/2022
Medication Guide Requirements..........
Applications for FDA Approval to Market 0910-0513 10/31/2022
a New Drug: Patent Submission and
Listing Requirements and Application of
30-month Stays on Approval of
Abbreviated New Drug Applications
Certifying That a Patent Claiming a
Drug Is Invalid or Will Not Be
Infringed..............................
Current Good Manufacturing Practice for 0910-0667 10/31/2022
Positron Emission......................
[[Page 72368]]
Abbreviated New Animal Drug Applications 0910-0669 10/31/2022
Medical Devices: Use of Certain Symbols 0910-0740 10/31/2022
in Labeling--Glossary to Support the
Use of Symbols in Labeling.............
Deeming Tobacco Products to be Subject 0910-0768 10/31/2022
to the Federal Food, Drug, and Cosmetic
Act....................................
Investigational Device Exemptions 0910-0078 11/30/2022
Reports and Records....................
510(k) Third-Party Review Program....... 0910-0375 11/30/2022
Guidance for Industry With the Center 0910-0454 11/30/2022
for Veterinary Medicine's Electronic
Submission System......................
------------------------------------------------------------------------
Dated: December 16, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-28249 Filed 12-30-19; 8:45 am]
BILLING CODE 4164-01-P